CIAS
MRNA icon

CFS Investment Advisory Services’s Moderna MRNA Stock Holding History

CFS Investment Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$300K Buy
1,774
+431
+32% +$126K 0.04% 192
2021
Q3 		$517K Buy
+1,343
New +$495K 0.07% 156

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CFS Investment Advisory Services's MRNA Position: Q4 2021 in Review

CFS Investment Advisory Services increased its Moderna (MRNA) stake by 32% in Q4 2021, buying an estimated $126K and bringing the position to 1,774 shares worth $300K. The position accounts for 0.04% of the portfolio, ranked #192.

CFS Investment Advisory Services first reported a position in MRNA in Q3 2021 and has held it in 2 quarters since. The position peaked at $517K in Q3 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • CFS Investment Advisory Services held 1,774 shares of Moderna worth $300K as of Q4 2021.
  • CFS Investment Advisory Services bought 431 Moderna shares in Q4 2021, an estimated $126K.
  • Moderna made up 0.04% of CFS Investment Advisory Services's portfolio in Q4 2021, its #192 holding.
  • CFS Investment Advisory Services first reported a position in Moderna in Q3 2021 and has held it in 2 quarters since.
  • CFS Investment Advisory Services's Moderna position peaked at $517K in Q3 2021.
  • 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on CFS Investment Advisory Services's 13F filing for Q4 2021, filed 14 Feb 2022.